BFM
XFOR icon

Boothbay Fund Management’s X4 Pharmaceuticals XFOR Stock Holding History

Boothbay Fund Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-343,963
Closed -$1.18M – 2427
2025
Q3 		$1.18M Buy
+343,963
New +$887K 0.02% 763
2023
Q3 		– Sell
-1,203
Closed -$70K – 2122
2023
Q2 		$70K Hold
1,203
– – ﹤0.01% 1653
2023
Q1 		$31.4K Hold
1,203
– – ﹤0.01% 2043
2022
Q4 		$35.8K Sell
1,203
-756
-39% -$35.8K ﹤0.01% 1900
2022
Q3 		$100K Sell
1,959
-4,040
-67% -$140K ﹤0.01% 2034
2022
Q2 		$174K Buy
5,999
+1,300
+28% +$49.5K ﹤0.01% 1809
2022
Q1 		$247K Sell
4,699
-3,253
-41% -$187K 0.01% 1752
2021
Q4 		$546K Sell
7,952
-967
-11% -$122K 0.01% 976
2021
Q3 		$1.42M Sell
8,919
-2,021
-18% -$333K 0.04% 595
2021
Q2 		$2.13M Buy
10,940
+655
+6% +$165K 0.07% 361
2021
Q1 		$2.66M Buy
10,285
+7,373
+253% +$1.94M 0.1% 235
2020
Q4 		$562K Buy
2,912
+353
+14% +$69.3K 0.02% 701
2020
Q3 		$520K Buy
+2,559
New +$613K 0.03% 631
2020
Q1 		– Sell
-528
Closed -$169K – 1089
2019
Q4 		$169K Buy
+528
New +$189K 0.01% 727

Other funds holding XFOR

EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Boothbay Fund Management's XFOR Position: Q4 2025 in Review

Boothbay Fund Management sold out of X4 Pharmaceuticals (XFOR) in Q4 2025, closing a stake of 343,963 shares — an estimated $1.18M sold.

Boothbay Fund Management first reported a position in XFOR in Q4 2019 and held it in 14 quarters. The position peaked at $2.66M in Q1 2021. 79 funds tracked by Wall St. Rank hold XFOR as of Q4 2025.

  • Boothbay Fund Management reported no remaining X4 Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 343,963 X4 Pharmaceuticals shares in Q4 2025, an estimated $1.18M.
  • Boothbay Fund Management first reported a position in X4 Pharmaceuticals in Q4 2019 and held it in 14 quarters.
  • Boothbay Fund Management's X4 Pharmaceuticals position peaked at $2.66M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.